tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Autolus Therapeutics’ Earnings Call Highlights Growth and Challenges
PremiumCompany AnnouncementsAutolus Therapeutics’ Earnings Call Highlights Growth and Challenges
2M ago
Autolus Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Autolus Therapeutics Reports Q2 2025 Financial Results
2M ago
Autolus Therapeutics: Strong Market Potential and Growth Opportunities Justify Buy Rating
Premium
Ratings
Autolus Therapeutics: Strong Market Potential and Growth Opportunities Justify Buy Rating
2M ago
Is AUTL a Buy, Before Earnings?
PremiumPre-EarningsIs AUTL a Buy, Before Earnings?
2M ago
Positive Outlook for Autolus Therapeutics Amid EU Approval and Strong Sales Performance
Premium
Ratings
Positive Outlook for Autolus Therapeutics Amid EU Approval and Strong Sales Performance
3M ago
Autolus announces EC granted marketing authorization for AUCATZYL
Premium
The Fly
Autolus announces EC granted marketing authorization for AUCATZYL
3M ago
Autolus Therapeutics announces positive CHMP opinion for obe-cel
PremiumThe FlyAutolus Therapeutics announces positive CHMP opinion for obe-cel
5M ago
Autolus Therapeutics presents clinical data updates at EHA Congress
Premium
The Fly
Autolus Therapeutics presents clinical data updates at EHA Congress
5M ago
Autolus Therapeutics’ Earnings Call: AUCATZYL’s Strong Start Amid Financial Challenges
Premium
Company Announcements
Autolus Therapeutics’ Earnings Call: AUCATZYL’s Strong Start Amid Financial Challenges
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100